Loading...
OTCM
BJTRF
Market cap604mUSD
, Last price  
Name

Beijing Tong Ren Tang Chinese Medicine Co Ltd

Chart & performance

D1W1MN
OTCM:BJTRF chart
P/E
—
P/S
—
EPS
0.47
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
2.84%
Div Yld LY
—
Div Yld TTM
—
Revenues
1.51b
-6.10%
333,039,000613,963,000761,051,000970,477,0001,084,280,0001,265,994,0001,513,873,0001,432,632,0001,315,346,0001,556,158,0001,731,095,0001,524,945,0001,611,644,0001,513,357,000
Net income
397m
-20.60%
155,935,000220,001,000287,124,000354,249,000420,315,000489,967,000580,720,000556,118,000542,456,000607,838,000645,875,000540,393,000500,278,000397,216,000
CFO
868m
P
185,096,000142,528,000244,734,000353,576,000467,721,000469,144,000577,684,000551,010,000116,054,000777,170,000547,444,000460,831,000-217,251,000868,234,000
Dividend
Jun 12, 20260.05102 /sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) is an entity primarily engaged in the manufacturing, retailing, and wholesale distribution of traditional Chinese medicine and various healthcare products, catering to both bulk purchasers and individual consumers. The company further provides traditional Chinese medical consultation and treatment services. Its operational scope is divided across three key regions: Hong Kong, Mainland China, and other international markets. With a substantial retail presence, it manages 23 outlets in Hong Kong and an additional 46 stores distributed across Asia, Oceania, North America, and Europe. All its merchandise is marketed under the well-known Tong Ren Tang brand. This historic firm, established in 1669, maintains its corporate headquarters in Wan Chai, Hong Kong.

Key people

Han Yan
Executive Chairman of the Board · since 2025
Fung Yi Tsang
Chief Financial Officer, Company Secretary · since 2020
Zheng Guo Shen
General Counsel, Deputy General Manager · since 2022
Wei Wu
Deputy General Manager · since 2020
Jiliang Zhang
Deputy General Manager · since 2022
Chi Wang
Chief Executive Officer, Executive Director · since 2024
Li Feng
Non-Executive Director · since 2023
Non-Executive Independent Director · since 2013
Independent Non-Executive Director · since 2017
Non-Executive Independent Director · since 2023
IPO date
May 07, 2013
Employees
789
Domiciled in
HK
Incorporated in
HK

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT